The 5-HT1A/1B-receptor agonist eltoprazine increases both catecholamine release in the prefrontal cortex and dopamine release in the nucleus accumbens and decreases motivation for reward and “waiting” impulsivity, but increases “stopping” impulsivity

Publication | Open Access

DOI Full Paper Access

Citations

121

References

2016

Year

S. Mechiel Korte, Jolanda Prins, Filip S. van den Bergh, Ronald S. Oosting, Rudy Dupree, G.A.H. Korte-Bouws, Koen G.C. Westphal, Berend Olivier, Damiaan Denys, Alexis Garland,

European Journal of Pharmacology

Behavioral NeuroscienceAddictionPrefrontal CortexBehavioral PharmacologyPharmacologyMedicinePsychopharmacologyImpulsivityNeuropharmacologyPharmacotherapyNeuroscienceCatecholamine ReleaseReward SystemDopamineCognitive NeuroscienceDopamine ReleaseSocial SciencesDopamine Research